arrow
S

Sophie Guillemard

institut national de la santé et de la recherche médicale (inserm)
H指数:5
被引数:138

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study

瑞戈非尼联合改良吉西他滨-奥沙利铂方案治疗晚期胆道癌。BREGO研究(随机 Ib/II 期)。

2025-06-010
OAAI
Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer

FDG PET代谢参数在不可手术的III期非小细胞肺癌患者接受42 Gy放化疗前后的预后价值

2025-02-270
PRE
Phase II Study of a Radiotherapy Total Dose Increase in Hypoxic Lesions Identified by 18F-Misonidazole PET/CT in Patients with Non-Small Cell Lung Carcinoma (RTEP5 Study)
2017-03-0270
OAAI